New Head for Daiichi Sankyo Germany: Jens Tuischer Takes Over Management
Published
The pharmaceutical company Daiichi Sankyo has announced a personnel decision for its German business. Jens Tuischer is taking over the management of Daiichi Sankyo Deutschland.
Daiichi Sankyo is a Japanese pharmaceutical company that develops and distributes medicines in various fields. The German subsidiary is responsible for sales and for cooperation with partners in Germany. The management is responsible for the strategy and organisation of the company in the country.
What specific plans Jens Tuischer has for the company's future in Germany is not yet known in detail. At the time of the report, no detailed information was available about his career or his predecessor either.
Personnel changes in management are common in large companies and are part of normal corporate development. For employees, partners and customers in Germany, such a change is often the moment when new priorities are set. Further information on this may be published by the company in the coming weeks.
Sources: Tagesspiegel Background
More Germany news
- Mercedes-Benz Halts Investment in German Plants and Weighs Closures
- Housing Benefit Cut Dropped: 1.3 Million Households Keep Wohngeld
- Align Technology unveils new innovations for Invisalign treatment
- Large Solar Park in Merbitz Feeds Electricity into the Grid
- Nvidia shares fall sharply: How safe is pension money?
- Telekom baut Rechenzentrum für Industrie und KI aus
- Autonomous Buses to Enter Everyday Life: TUM Leads New DZM Site
- Cigarettes from the EU Abroad: Duty-Free Allowance Not Dropping for Now